Jamie Goldstein
Founder and Chairman @ Petri
Boston, United States
Jamie Goldstein is a seed investor at Petri in Boston focused on Artificial Intelligence and Software. Jamie Goldstein is the Founding Partner of Pillar VC. He previously worked at LBRY as a Board Member and Investor. Jamie Goldstein attended Massachusetts Institute of Technology.
- Total investments:
- 70
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries Jamie Goldstein invests in
Stages Jamie Goldstein invests in
Countries Jamie Goldstein invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Artificial Intelligence 9 (13%)
- Software 7 (10%)
- Health Care 7 (10%)
- Biotechnology 7 (10%)
- Information Technology 7 (10%)
Stage
- Seed 22 (31%)
- Series A 12 (17%)
- Series B 9 (13%)
- Series C 5 (7%)
- Funding Round 4 (6%)
Country
- United States 35 (50%)
- United Kingdom 1 (1%)
- The Netherlands 1 (1%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Addis Energy
|
Addis Energy is on a mission to alter the way we feed and fuel our society, harnessing the Earth's potential for clean ammonia production. | $8.3M / Seed / Dec 01, 2025 | |
Matterworks
|
Matterworks is a biotech startup that combines metabolomics with AI to simulate the metabolic environment. The startup is enabling real-time insights into cellular biology to accelerate therapeutic research, development, and manufacturing with an AI-driven cloud platform for metabolomics.Matterworks was founded by Mimoun Cadosch Delmar and JackGeremia in 2019. | Series A / Jun 03, 2025 | |
LightSource
|
LightSource develops a supply chain management platform to help professionals collaborate with their suppliers. It also allows collaborating with teammates on strategic sourcing projects, sending RFQs to suppliers and collecting quotes, and comparing bids using insights automatically extracted from the normal day-to-day work.The company wasfounded in 2021 and is headquartered in San Francisco, California. | $33M / Series A / Mar 31, 2025 | |
Videa
|
VideaHealth is offers dentistAI’s software automatically detects pathologies in dental imaging, helping dentists avoid missing diseases and effectively communicating treatment recommendations to patients. Today, dentists miss up to 50% of pathologies in dental x-rays. Treatment delays or non-treatment often results in significant health risks forthe patient and a loss of revenue for the dentists as he cannot treat missed diseases. | $40M / Series B / Jan 28, 2025 | |
|
Addis Energy
|
Addis Energy is on a mission to alter the way we feed and fuel our society, harnessing the Earth's potential for clean ammonia production. | $4.3M / Pre-Seed / Jan 21, 2025 | |
Adaptilens
|
Adaptilens develop an accommodating intraocular lens. Adaptilen's mission is to bring to market an accommodative intraocular lens that mimics the natural human lens so that patients will have excellent near and distance vision without eyeglasses or contact lenses. | $17.5M / Series A / Apr 29, 2024 | |
Asimov
|
Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies. | $175M / Series B / Jan 05, 2023 | |
Abridge
|
Abridge provides an AI platform that transforms patient-clinician conversations into structured, billable clinical notes. This technology aims to reduce documentation burdens for clinicians and nurses. The system integrates into existing healthcare workflows and electronic health record systems. | $12.5M / Series A / Aug 11, 2022 | |
AnyQuestion
|
You ask the questions, the world’s top experts share their answers. | Seed / Apr 01, 2022 | |
|
Videa
|
VideaHealth is offers dentistAI’s software automatically detects pathologies in dental imaging, helping dentists avoid missing diseases and effectively communicating treatment recommendations to patients. Today, dentists miss up to 50% of pathologies in dental x-rays. Treatment delays or non-treatment often results in significant health risks forthe patient and a loss of revenue for the dentists as he cannot treat missed diseases. | $20M / Series A / Mar 31, 2022 | |
| See all 70 investments → | |||
Co-Investors
About Petri
Petri is a new approach for funding formation-stage startups at the intersection of biology and engineering. Petri is co-founded by entrepreneurs who have built iconic companies as well as academics who are driving foundational science in bioengineering; together we have deep experience developing ideas into successful companies across humanhealth and sustainability.We invest pre-seed and seed capital and work one-on-one with founders for 12+ months. We help founders build world-class teams, develop intellectual property, find customers, and raise a subsequent round of financing.
Petri Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Brian Baynes
Founder
|
|||
|
Jamie Goldstein
Founder and Chairman
|
|||
|
Jaye Goldstein
Head of Program
|
|||
Josh Moser
Partner
|
|||
Tony Kulesa
Founder, Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Jamie Goldstein invest in?
Jamie Goldstein invests primarily in Artificial Intelligence, Software and Health Care startups, most often at Seed and Series A stage. Most of the 70 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Jamie Goldstein?
Public channels for Jamie Goldstein include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Jamie Goldstein last invest?
The most recent investment recorded for Jamie Goldstein closed in Dec 2025. Shizune tracks 70 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
